BOSCIA, GIACOMO
 Distribuzione geografica
Continente #
NA - Nord America 1.387
AS - Asia 977
EU - Europa 666
SA - Sud America 210
Continente sconosciuto - Info sul continente non disponibili 135
AF - Africa 48
Totale 3.423
Nazione #
US - Stati Uniti d'America 1.326
SG - Singapore 473
IT - Italia 314
BR - Brasile 161
HK - Hong Kong 128
CN - Cina 119
VN - Vietnam 97
DE - Germania 79
RU - Federazione Russa 74
FR - Francia 53
BD - Bangladesh 29
CA - Canada 29
IN - India 28
GB - Regno Unito 26
NL - Olanda 21
FI - Finlandia 20
AR - Argentina 18
PL - Polonia 16
ZA - Sudafrica 15
MX - Messico 14
ID - Indonesia 13
IQ - Iraq 13
JP - Giappone 13
ES - Italia 12
PK - Pakistan 11
SA - Arabia Saudita 9
VE - Venezuela 9
CO - Colombia 8
SE - Svezia 8
AT - Austria 7
TR - Turchia 7
BE - Belgio 6
LT - Lituania 6
MA - Marocco 6
PH - Filippine 6
CL - Cile 5
CR - Costa Rica 5
CI - Costa d'Avorio 4
CZ - Repubblica Ceca 4
EG - Egitto 4
JM - Giamaica 4
TN - Tunisia 4
UA - Ucraina 4
UZ - Uzbekistan 4
AE - Emirati Arabi Uniti 3
CH - Svizzera 3
EC - Ecuador 3
ET - Etiopia 3
IL - Israele 3
KE - Kenya 3
PT - Portogallo 3
BO - Bolivia 2
DO - Repubblica Dominicana 2
GR - Grecia 2
HN - Honduras 2
KZ - Kazakistan 2
NG - Nigeria 2
PS - Palestinian Territory 2
PY - Paraguay 2
QA - Qatar 2
SC - Seychelles 2
SK - Slovacchia (Repubblica Slovacca) 2
TH - Thailandia 2
UY - Uruguay 2
AM - Armenia 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BH - Bahrain 1
CU - Cuba 1
EE - Estonia 1
GA - Gabon 1
GE - Georgia 1
GH - Ghana 1
IE - Irlanda 1
JO - Giordania 1
KG - Kirghizistan 1
KH - Cambogia 1
KN - Saint Kitts e Nevis 1
KR - Corea 1
KW - Kuwait 1
LB - Libano 1
LK - Sri Lanka 1
MR - Mauritania 1
NI - Nicaragua 1
NP - Nepal 1
OM - Oman 1
PA - Panama 1
RE - Reunion 1
RO - Romania 1
RS - Serbia 1
SY - Repubblica araba siriana 1
TT - Trinidad e Tobago 1
Totale 3.288
Città #
Singapore 270
San Jose 220
Ashburn 215
Hong Kong 126
Elk Grove Village 91
Milan 79
Council Bluffs 64
Beijing 59
Los Angeles 53
Dallas 40
New York 40
Buffalo 36
Lauterbourg 34
Ho Chi Minh City 33
Rome 32
Columbus 27
Falkenstein 27
Santa Clara 24
Boardman 23
Hanoi 22
Munich 22
Bari 17
São Paulo 17
Frankfurt am Main 15
Warsaw 15
Helsinki 14
Orem 13
Atlanta 12
Tokyo 12
Jakarta 11
Montreal 11
Brooklyn 9
Phoenix 9
Amsterdam 8
Johannesburg 8
London 8
Mexico City 8
Stockholm 8
Chicago 7
Figino 7
Naples 7
Toronto 7
Turin 7
Belo Horizonte 6
Chennai 6
Houston 6
Poplar 6
Seattle 6
Baghdad 5
Brussels 5
Campinas 5
Carmiano 5
Denver 5
Fortaleza 5
Hải Dương 5
Moscow 5
Nuremberg 5
Rio de Janeiro 5
Abidjan 4
Casamassima 4
Da Nang 4
Dhaka 4
Jeddah 4
Lahore 4
Madrid 4
Manchester 4
Palermo 4
Philadelphia 4
Portsmouth 4
San José 4
Shanghai 4
Tashkent 4
Washington 4
Acalanes Ridge 3
Addis Ababa 3
Ankara 3
Birmingham 3
Bogotá 3
Boston 3
Brasília 3
Brno 3
Casablanca 3
Charlotte 3
Cleveland 3
Curitiba 3
Düsseldorf 3
Espoo 3
Guarulhos 3
Hillsboro 3
Joinville 3
Kingston 3
Medina 3
Memphis 3
Nairobi 3
Natal 3
New Delhi 3
Queens 3
San Francisco 3
Santo André 3
Vienna 3
Totale 1.988
Nome #
FUNCTIONAL AND ANATOMICAL OUTCOMES AFTER SHORT-TERM HEAVY SILICONE OIL ENDOTAMPONADE FOR INFERIOR RHEGMATOGENOUS RETINAL REDETACHMENT: A Pilot Study 115
Choroidal remodeling following different anti-VEGF therapies in neovascular AMD 110
Anterior chamber bleeding due to intravitreal dexamethasone implant sclerotomy without vitreous hemorrhage 110
Biofeedback Training after Successful Inverted Internal Limiting Membrane (ILM)-Flap Technique for High Myopic Macular Hole 107
Long-Term Impact of Diabetic Retinopathy on Response to Anti-VEGF Treatment in Neovascular AMD 107
Evaluation of the Efficacy of Ozonated Oil in Liposomes as an Adjuvant in Intravitreal Injection Prophylaxis: OPERA Study 106
Neurovascular retinal impairment in early-treated adults with phenylketonuria 99
Micropulse Laser versus Eplerenone for Chronic Central Serous Chorioretinopathy: A 12-Month Comparison 97
Comparative Study on Anti-VEGF in Wet Age-Related Macular Degeneration in the Setting Based on Lean Methodology from the Bari Intravitreal Injection Registry (BIVIR) 97
Analysis of Choriocapillaris Reperfusion Topography Following Faricimab Treatment for Neovascular Age-Related Macular Degeneration in Therapy-Naïve Patients 94
Liposomal Ozonated Oil Ensures a Further Reduction in the Microbial Load Before Intravitreal Injection: the "OPERA" Study 94
Effect of Pro Re Nata Regimen with Anti-VEGF on Type 3 Macular Neovascularization: Long-Term Outcomes 91
Continuous Eplerenone Treatment in Chronic Central Serous Chorioretinopathy: Long-Term Results from a Pilot Study 90
Analysis of Choriocapillaris Reperfusion Topography following Faricimab Treatment for Neovascular Age-Related Macular Degeneration in Non-Treatment-Naïve Patients 89
Real-World Outcomes of a Loading Phase with Intravitreal Faricimab in Neovascular Age-Related Macular Degeneration (n-AMD) and Diabetic Macular Edema (DME) 86
Topographical Quantification of Hyper-Reflective Foci May Predict the Development of Macular Atrophy in Patients With Neovascular Age-Related Macular Degeneration 84
Immediate effect of anti-VEGF injections on optic nerve head: Correlation between intraocular pressure and anatomical peripapillary changes 77
Xen gel stent implant for persistent glaucoma after silicone oil removal 76
Multifocal Electroretinography Changes in Patients with Late-Stage Age-Related Macular Degeneration (AMD) After Smaller-Incision New-Generation Implantable Miniature Telescope (SING IMT): A Case Series 75
Microperimetric evaluation and predictive factors of visual recovery after successful inverted internal limiting membrane-flap technique for macular hole in high myopic eyes 75
Effects of diabetic retinopathy on longitudinal morphological changes in AMD-associated type 1 macular neovascularization 74
Photobiomodulation-induced choriocapillaris perfusion enhancement and outer retinal remodelling in intermediate age-related macular degeneration: a promising therapeutic approach with short-term results 74
Choriocapillaris flow in two different patterns of exudative type 1 macular neovascularization 73
Choriocapillaris Reperfusion in Resolved Chronic Central Serous Chorioretinopathy Treated with Eplerenone: Long-Term Effects on the Fellow Eye 70
Twelve-Month Outcomes and Optical Coherence Tomography (OCT) Biomarkers After Intravitreal Dexamethasone Implantation in Pseudophakic Eyes with Post-Vitrectomy Cystoid Macular Edema (CME)—Refractory to Medical Therapy 69
LONG-TERM VISUAL OUTCOMES AND OPTICAL COHERENCE TOMOGRAPHY BIOMARKERS IN EYES WITH MACULAR EDEMA SECONDARY TO RETINAL VEIN OCCLUSION FOLLOWING ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY 68
SEVERE VISUAL LOSS DURING ANTI-VEGF INTRAVITREAL INJECTIONS IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION Timing, Prognosis and Optical Coherence Tomography Findings 66
Subthreshold micropulse laser treatment for autosomal recessive bestrophinopathy complicated by macular neovascularization 66
Short-term peripapillary structural and vascular changes following anti-VEGF vs. Dexamethasone intravitreal therapy in patients with DME 65
Intraoperative OCT-Guided Selective Epiretinal Membrane (ERM) Peeling Versus ERM and Internal Limiting Membrane Peeling for Tractional Macular Edema in Diabetic Eyes 65
Long-term Eplerenone treatment in chronic central serous chorioretinopathy: effects on affected and fellow eye 63
The Impact of Diabetic Retinopathy on the Choriocapillaris in Neovascular AMD 61
Ocular Side Effects of Dupilumab: A Comprehensive Overview of the Literature 57
Optical coherence tomography biomarkers indicating visual enhancement in diabetic macular edema resolved through anti-VEGF therapy 56
Relationship of Topographic Distribution of Macular Atrophy Secondary to Neovascular AMD and Reading Performance 54
INTERSESSION REPEATABILITY OF READING PERFORMANCE MEASURES IN PATIENTS WITH NEOVASCULAR AGE-RELATED MACULAR DEGENERATION 53
Factors influencing the number of anti-VEGF injections in myopic choroidal neovascularization: a multicenter study 49
Intravitreal Dexamethasone Implant in Vitreoretinal Surgery: An Overview of the Literature 49
Ellipsoid zone reflectivity changes after idiopathic epiretinal membrane peeling: a pilot study 46
Optimizing resolution for type 1 macular neovascularization detection in pachychoroid disease: A 3 × 3 vs 6 × 6 mm SS-OCTA comparative study 41
Visual and anatomical evaluation of navigated subthreshold micropulse laser versus photodynamic therapy in managing chronic central serous chorioretinopathy 41
RWC Update: Uveal Effusion Syndrome; Peeling the Internal Limiting Membrane in Epiretinal Membrane Surgery; Partially Scrambled Best Disease 40
Comparison of Rescue Approach with Gore-Tex Suture Scleral Fixation and Lens Explantation Combined with Standardized Flanged Intrascleral Fixation 37
Recalcitrant macular edema after pseudophakic rhegmatogenous retinal detachment repair: risk factors and response to intravitreal dexamethasone implant 34
Choroidal Layer Analysis Under Flat Irregular Pigment Epithelial Detachments in Central Serous Chorioretinopathy 31
Choroidal Remodeling After Subthreshold Micropulse Laser in Chronic Central Serous Chorioretinopathy: Short-Term Outcomes 30
Evaluation of choriocapillaris perfusion changes in chronic central serous chorioretinopathy following Half-Dose photodynamic therapy 29
Impact of diabetes and diabetic retinopathy on neovascular exudative age‐related macular degeneration 26
Incidence and reasons for discontinuation of anti-VEGF treatment in neovascular age-related macular degeneration 25
Pachychoroid disease spectrum: how multimodal imaging and OCT angiography have improved our knowledge 13
The prognostic role of video head-impulse test in the clinical evaluation of chronic vestibular damage: A brief case series 12
Amniotic Membrane-Assisted Corneal Transplantation in Ocular Perforation Due to GVHD: A Case Report 7
Totale 3.423
Categoria #
all - tutte 11.106
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 11.106


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2022/20236 0 0 0 0 0 0 0 0 0 0 0 6
2023/202433 1 4 1 7 3 3 0 2 0 8 0 4
2024/2025641 16 0 6 25 12 82 68 81 48 53 97 153
2025/20262.373 274 86 98 162 378 224 203 111 354 238 67 178
2026/2027370 122 101 147 0 0 0 0 0 0 0 0 0
Totale 3.423